Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis

Salvatore Pece1, Michela Serresi, Elisa Santolini

  • 1Istituto Europeo di Oncologia, 20141 Milan, Italy.

Insights

The Numb protein suppresses tumors by regulating Notch signaling. Loss of Numb in breast cancer leads to increased Notch activity, driving tumor growth and offering a therapeutic target.

Area of Science:

  • Cellular Biology
  • Developmental Biology
  • Oncology

Background:

  • The Notch and Numb pathways are critical for cellular balance during development and tissue maintenance.
  • Aberrant Notch signaling is implicated in various diseases, including cancer, but its direct role in human tumors requires further elucidation.
  • Understanding the interplay between Notch and Numb is crucial for comprehending cancer development.

Purpose of the Study:

  • To investigate the role of the Numb/Notch antagonism in human mammary carcinomas.
  • To determine if Numb acts as a tumor suppressor in breast cancer.
  • To explore the therapeutic potential of targeting Notch signaling in Numb-deficient breast tumors.

Main Methods:

  • Analysis of Numb protein levels and ubiquitination status in human breast cancer samples.
  • Assessment of Notch signaling activity in relation to Numb expression.
  • Experimental manipulation of Numb expression in breast cancer cell lines and normal breast cells.
  • Evaluation of tumor growth inhibition following ectopic Numb expression or Notch pathway blockade.

Main Results:

  • Numb-mediated regulation of Notch signaling is disrupted in approximately 50% of human breast cancers due to Numb degradation.
  • Numb functions as an oncosuppressor; its reintroduction inhibits proliferation in Numb-negative cancer cells.
  • Numb loss correlates with elevated Notch signaling in tumors, which is reversed by Numb restoration.
  • Pharmacological inhibition of Notch effectively suppresses tumor growth in Numb-negative, but not Numb-positive, breast cancers.

Conclusions:

  • The Numb/Notch pathway is vital for mammary gland homeostasis, and its disruption contributes significantly to breast carcinogenesis.
  • Numb acts as a critical tumor suppressor in the breast, with its loss being a key event in tumor development.
  • Targeting the Notch pathway represents a promising therapeutic strategy for breast cancers characterized by Numb deficiency.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...